Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model

DOI: 10.1371/journal.pone.0213095

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text